Literature DB >> 34051478

Gist of Zika Virus pathogenesis.

Utkarsh Bhardwaj1, Neha Pandey1, Meghana Rastogi1, Sunit K Singh2.   

Abstract

Zika virus (ZIKV) is a mosquito-borne neurotropic flavivirus. ZIKV infection may lead to microcephaly in developing fetus and Guillain-Barré Syndrome (GBS) like symptoms in adults. ZIKV was first reported in humans in 1952 from Uganda and the United Republic of Tanzania. Later, ZIKV outbreak was reported in 2007 from the Yap Island. ZIKV re-emerged as major outbreak in the year 2013 from French Polynesia followed by second outbreak in the year 2015 from Brazil. ZIKV crosses the blood-tissue barriers to enter immune-privileged organs. Clinical manifestations in ZIKV disease includes rash, fever, conjunctivitis, muscle and joint pain, headache, transverse myelitis, meningoencephalitis, Acute Disseminated Encephalomyelitis (ADEM). The understanding of the molecular mechanism of ZIKV pathogenesis is very important to develop potential diagnostic and therapeutic interventions for ZIKV infected patients.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostics; Host receptors; Host-virus immune response; Therapeutics; Virus transmigration; Virus transmission; Zika virus

Mesh:

Year:  2021        PMID: 34051478     DOI: 10.1016/j.virol.2021.04.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  1 in total

1.  Zika Virus NS1 Suppresses VE-Cadherin and Claudin-5 via hsa-miR-101-3p in Human Brain Microvascular Endothelial Cells.

Authors:  Utkarsh Bhardwaj; Sunit K Singh
Journal:  Mol Neurobiol       Date:  2021-09-06       Impact factor: 5.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.